Jefferies Reiterates Buy on Mankind Pharma, TP ₹3,000

📊

continues to receive a 'Buy' rating from Jefferies Financial Group with a target price of ₹3,000. The brokerage cited early signs of business turnaround and said it prefers Mankind Pharma over Dr. Reddy's Laboratories Limited and Cipla Limited within the sector.